Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Growth Hormone Receptor Antibodies:
anti-Mouse (Murine) Growth Hormone Receptor Antibodies:
anti-Rat (Rattus) Growth Hormone Receptor Antibodies:
Go to our pre-filtered search.
Human Polyclonal Growth Hormone Receptor Primary Antibody for IF (p), IHC (p) - ABIN671481
Wang, Zhou, Lin, Wang, Lin, Li: RhGH attenuates ischemia injury of intrahepatic bile ducts relating to liver transplantation. in The Journal of surgical research 2011
Show all 6 Pubmed References
Human Polyclonal Growth Hormone Receptor Primary Antibody for CyTOF, FACS - ABIN4900013
Zhang, Hatano, Shaw, Olde Nordkamp, Jiang, Li, Kollnberger: The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains. in PLoS ONE 2015
Show all 2 Pubmed References
Human Polyclonal Growth Hormone Receptor Primary Antibody for IHC (p), IHC - ABIN441424
Xekouki, Pacak, Almeida, Wassif, Rustin, Nesterova, de la Luz Sierra, Matro, Ball, Azevedo, Horvath, Lyssikatos, Quezado, Patronas, Ferrando, Pasini, Lytras, Tolis, Stratakis: Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? in The Journal of clinical endocrinology and metabolism 2012
GHRH (show GHRH Antibodies) and GHRH-R (show GHRHR Antibodies) are expressed in human adipocytes and are negatively associated; GHRH (show GHRH Antibodies) at low doses may exert an anti-obesity effect by inhibiting HMSC differentiation in adipocytes and by increasing adipocyte lipolysis in an autocrine or paracrine pathway; these effects are mediated by GH and GH-R
Genetic variations at the human growth hormone receptor gene locus are associated with idiopathic short stature.
Short small for gestational age children carrying the d3-GHR polymorphism had increased spontaneous growth, lower Insulin (show INS Antibodies) sensitivity and a compensatory increase in glucose, C-peptide and insulin (show INS Antibodies) before GH therapy compared to children homozygous for the full-length allele.
In a meta-analysis of a combined group of 324 acromegaly patients obtained from 4 separate study cohorts, the presence of 1 or 2 copies of the exon 3 deletion-GHR polymorphism had no significant effect on the lowest insulin-like growth factor I (show IGF1 Antibodies) levels during pegvisomant treatment nor on the required pegvisomant dose to achieve these levels.
Data suggest that subjects with 6Psi GHR point mutation [intronic GHR pseudoexon mutation 6Psi, base change A(-1) to G(-1) in intron 6] exhibit heterogeneity in phenotype and in response to therapy with rhIGF1 (recombinant human insulin-like growth factor I (show IGF1 Antibodies)); there is mismatch between clinical and biochemical features in patients with this GHR mutations; rhIGF1 treatment improves target height outcomes in these patients.
these results show that GHR polymorphism is associated with the length and width of the lip
Our set of findings identify an unknown mechanism of GH regulation in mediating melanoma drug resistance and validates GHR as a unique therapeutic target for sensitizing highly therapy-resistant human melanoma cells to lower doses of anti-cancer drugs.
The results suggest that both of the possible single mutation-containing heteromeric GH-GHR complexes, as well as the double GHR mutant complex result in perturbation of complex structures, with altered ability of the GHR dimers to interact with the GH peptide.
These results implicate TIMP3 (show TIMP3 Antibodies) as a modulator of cell surface GHR abundance and the ability of GH to promote cellular signaling.
GHR and PRLR (show PRLR Antibodies) associate in complexes comprised of GHR-GHR/PRLR-PRLR (show PRLR Antibodies) heteromers consisting of GHR homodimers and PRLR (show PRLR Antibodies) homodimers, rather than GHR-PRLR (show PRLR Antibodies) heterodimers.
GHR -/- mice had decreased body weight but increased percent fat mass. Serum FGF21 (show FGF21 Antibodies) levels were unchanged in GHR -/- mice. Expression of Fgf21 (show FGF21 Antibodies), Fgfr1 (show FGFR1 Antibodies), and Klb (show KLB Antibodies) mRNA in white AT and liver were downregulated or unchanged inGHR -/- mice. The only exception was Fgf21 (show FGF21 Antibodies) expression in brown AT of GHR -/-, which trended toward increased expression.
A role for GH in influencing hormone signaling in adipose tissue in a depot-dependent manner in GHR-/- knock-out mice.
disruption of cardiomyocyte GH-induced signaling in adult GhrKO mice does not affect cardiac function, but it does play a role in systemic glucose homeostasis, in part through modulation of circulating IGF-1 (show IGF1 Antibodies).
Snell, GHKRO, and PAPPA (show PAPPA Antibodies)-KO mice express high levels of two proteins involved in DNA repair, O-6-methylguanine-DNA methyltransferase (MGMT (show MGMT Antibodies)) and N-myc downstream-regulated gene 1 (NDRG1 (show NDRG1 Antibodies)).
adult-onset growth hormone receptor knockout mice (aGHRKO mice), like GHRKO animals, displayed retarded growth and high adiposity with improved insulin (show INS Antibodies) sensitivity. Importantly, female aGHRKO animals showed an increase in their maximal lifespan, whereas the lifespan of male aGHRKO mice was not different from controls.
Similar to other mice with decreased GH action, female GHA mice display reduced age-related lipid redistribution and improved insulin (show INS Antibodies) sensitivity, but no change in cellular senescence.
The dwarf phenotype was partially corrected via plasmid containing the growth hormone gene administrated intramuscularly, depending on age at treatment.
GHR-dependent downregulation of NLRP3 (show NLRP3 Antibodies) inflammasome in macrophages is linked to pro-longevity effects that maintain immune system homeostasis in aging.
both brown adipose tissue (BAT (show BAAT Antibodies)) and white adipose tissue (WAT) contribute in different ways to phenotypes in GHRKO mice, with Ghr ablation blunting inflammation in BAT (show BAAT Antibodies) as well as cellular metabolism and mitochondrial biogenesis in WAT
Data (including data from studies in knockout mice) suggest Socs2 (suppressor of cytokine signaling 2 (show SOCS2 Antibodies)) regulates liver regeneration rate after partial hepatectomy, Ghr level via ubiquitination/proteolysis, and serum Igf1 (insulin-like growth factor-1 (show IGF1 Antibodies)).
There was no association between the genotypes of GH and IGF-IS and fertility of Holstein cows raised in semiextensive or intensive regimes, while the STAT5 (show STAT5A Antibodies) ABstEII polymorphism was associated with calving-first heat interval in Holstein cows raised in the intensive system.
hepatic growth hormone receptor and suppressor of cytokine signaling (SOCS (show CISH Antibodies))2 (show SOCS2 Antibodies) messenger RNA expression appeared to be promptly and sensitively regulated by increased estradiol levels before ovulation of dairy heifers
Comparatively studied genetic diversity of growth hormone receptor (GHR) in Tibetan cattle and Chinese Holstein cow.
This work confirms the importance of CAPN1 (show CAPNL1 Antibodies) and CAST for tenderness in beef, provides a new effect of CAST on beef tenderness, and questions the utility of GHR as a selection marker for beef quality.
the data support the high potential of the growth hormone receptor F279Y polymorphism as a marker for the improvement of milk traits in selection programs
6 of the published GHR SNPs and 7 of the novel GHR SNPs were associated with at least 1 of the traits--milk yield, fat yield, protein yield, fat percentage, protein percentage, somatic cell score, calving interval, survival and growth and size traits.
Effects of GHR p.Phe279Tyr mutations on milk, fat and protein yield, as well as fat and protein percentage in the milk of 1222 Holstein cows was found to be significantly associated with protein percentage.
Food deprivation-induced decrease in circulating IGF-I (show IGF1 Antibodies) in steers is associated with decrease in expression of different IGF-I (show IGF1 Antibodies) mRNA variants and specific decrease in expression of growth hormone receptor mRNA variants 1C3 and 1A in liver.
Insulin (show INS Antibodies) regulates the efficiency of GH signaling in liver and adipose tissue of dairy cows by acting as a rheostat of GHR synthesis.
Results show that chicken ovalbumin upstream promoter transcription factor (show NR2F1 Antibodies) II (COUP-TFII (show NR2F2 Antibodies)), hepatocyte nuclear factor 4alpha (HNF-4alpha (show HNF4A Antibodies)) and HNF-4gamma regulate growth hormone receptor 1A promoter activity by binding to a common DNA element
Castration significantly reduced the serum growth hormone (show GH1 Antibodies) and the responses of the growth hormone receptor (GHR)
GHR double-allelic knockout pigs were 50% smaller than that of the controls.
Growth hormone (GH (show GH1 Antibodies)) in maturation medium did not increase cumulus expansion in porcine cumulus-oocyte complexes but did improve nuclear maturation, GH had no effect on porcine fertilization and embryo development.
subunit alignment is critical for effective signaling in GH receptor activation
Fos-zippered GHR tails and Jak2 (show JAK2 Antibodies), both purified from baculovirus-infected insect cells, interacted via box1 with a binding affinity of approximately 40nM.
Jak2 (show JAK2 Antibodies) binding to the growth hormone receptor prevents endocytosis in a non-catalytic manner
GHR gene may be a candidate gene responsible for butcher trait in rabbit.
This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.
, growth hormone binding protein
, serum binding protein
, somatotropin receptor
, Growth hormone receptor precursor (GH receptor) (GH binding protein) (GHBP) (Serum binding protein)
, growth hormone receptor/binding protein
, growth hormone receptor precursor splice variant D56
, growth hormone receptor variant d5-6
, growth hormone receptor
, growth hormone-binding protein
, serum-binding protein
, Somatotropin receptor